Question 1

What is Corvus Pharmaceuticals?

Accepted Answer

Corvus Pharmaceuticals is a Company.

Question 2

How often does Corvus Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Corvus Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on May 07, 2026.

Question 4

When was Corvus Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is Corvus Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Corvus Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Corvus Pharmaceuticals?

Accepted Answer

Corvus Soquelitinib Phase 1 Atopic Dermatitis Data (May 07, 2026, 7 articles).

Question 8

How did the "Corvus Soquelitinib Phase 1 Atopic Dermatitis Data" event impact Corvus Pharmaceuticals?

Accepted Answer

Corvus Pharmaceuticals announced positive final data from its Phase 1 trial of soquelitinib for atopic dermatitis, supporting its potential for drug-free remissions and advancing its clinical development. This positive news is expected to boost investor confidence and potentially its stock price.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.